Drug company Medivation Inc. cut its Q1 loss in half to $8.5 million.
A year earlier the San Francisco company (NASDAQ: MDVN) lost $17.5 million.
Revenue was about flat -- $14.7 million in the March quarter compared with $15.7 million a year earlier.
No comments:
Post a Comment